Boxer Capital’s Cullinan Oncology CGEM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-907,895
| Closed | -$15.2M | – | 10 |
|
2024
Q3 | $15.2M | Buy |
907,895
+250,000
| +38% | +$4.19M | 0.75% | 37 |
|
2024
Q2 | $11.5M | Buy |
+657,895
| New | +$11.5M | 0.6% | 41 |
|
2023
Q4 | – | Sell |
-1,074,082
| Closed | -$9.72M | – | 56 |
|
2023
Q3 | $9.72M | Hold |
1,074,082
| – | – | 0.52% | 41 |
|
2023
Q2 | $11.6M | Hold |
1,074,082
| – | – | 0.54% | 46 |
|
2023
Q1 | $11M | Hold |
1,074,082
| – | – | 0.54% | 42 |
|
2022
Q4 | $11.3M | Hold |
1,074,082
| – | – | 0.6% | 42 |
|
2022
Q3 | $13.8M | Hold |
1,074,082
| – | – | 0.77% | 40 |
|
2022
Q2 | $13.8M | Hold |
1,074,082
| – | – | 0.87% | 39 |
|
2022
Q1 | $11.2M | Hold |
1,074,082
| – | – | 0.58% | 42 |
|
2021
Q4 | $16.6M | Hold |
1,074,082
| – | – | 0.64% | 35 |
|
2021
Q3 | $24.2M | Hold |
1,074,082
| – | – | 0.85% | 34 |
|
2021
Q2 | $27.7M | Hold |
1,074,082
| – | – | 0.98% | 28 |
|
2021
Q1 | $44.8M | Buy |
+1,074,082
| New | +$44.8M | 1.52% | 18 |
|